Iradimed IRMD
NASDAQ IRMD
$83.41 -0.99 (-1.17%)
As of: Sep 9, 2026 · 3:59 PM EDT

Iradimed (IRMD) Revenue Growth (3y) (2016 - 2026)

Analysis

Iradimed (IRMD) Revenue Growth (3y) (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 8.07%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 18.10%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 8.20%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 9.66%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 14.78%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 10.83%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 4.73%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 14.51%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 8.05%
10 Iradimed 1.07 Bn 1.01 Bn 15.16 Mn 8.26%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.26%
Mar 31, 2026 12.41%
Dec 31, 2025 15.15%
Sep 30, 2025 16.51%
Jun 30, 2025 17.06%
Mar 31, 2025 16.59%
Dec 31, 2024 17.76%
Sep 30, 2024 18.88%
Jun 30, 2024 22.26%
Mar 31, 2024 24.03%
Dec 31, 2023 26.87%
Sep 30, 2023 28.94%
Jun 30, 2023 33.40%
Mar 31, 2023 21.27%
Dec 31, 2022 10.92%
Sep 30, 2022 10.40%
Jun 30, 2022 11.31%
Mar 31, 2022 13.42%
Dec 31, 2021 12.50%
Sep 30, 2021 12.73%